Loading organizations...
Loading organizations...
Biotechnology company developing therapeutics for CNS diseases.
Bolden Therapeutics has raised $1.5M across 1 funding round.
Bolden Therapeutics has raised $1.5M in total across 1 funding round.
Bolden Therapeutics has raised $1.5M in total across 1 funding round.
Bolden Therapeutics's investors include Resolute Venture Partners, Andrew Worden, Slater Technology Fund.
Bolden Therapeutics has raised $1.5M across 1 funding round. Most recently, it raised $1.5M Pre-Seed in January 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 22, 2024 | $1.5M Pre-Seed | Resolute Venture Partners | Andrew Worden, Slater Technology Fund |